Oramed Pharmaceuticals Inc. (ORMP) Earnings
|
Expand Research on ORMP
| Next EPS Date | 8/13/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +126.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/26  |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/17/25 | Q325 | $0.15 | -$0.04 | +$0.19 | $1.18M | N/A | N/A |  | | Details | |
| 11/14/25 |
Q325 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/26/25 |
Q225 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/25/25 |
Q225 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/25 |
Q225 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/25 |
Q225 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A |
